홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RLMD
#2641
Relmada Therapeutics, Inc. Common Stock
7.1
9
USD
-2.57%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-2.57%
월간 변동
+20.23%
6달 변화
+272.54%
년간 변동율
+2296.67%
이전 종가
7.3
8
Open
7.1
9
Bid
Ask
Low
7.1
9
High
7.1
9
양
48
마켓
주식
헬스케어
RLMD
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
16.75 M
29.37 M
30.1 M
30.17 M
33.19 M
104.89 M
—
Valuation ratios
Enterprise value
534.55 M
617.25 M
95.74 M
127.77 M
13.4 M
503.12 M
675.52 M
Price to earnings ratio
—
—
-0.63
-1.33
-0.2
-3.33
-4.83
Price to sales ratio
—
—
11.05
25.53
41.84
-2 407.45
-1 484.64
Price to cash flow ratio
—
—
-0.96
-2.55
-0.3
-4.16
-6.25
Price to book ratio
—
—
0.71
1.54
0.44
2.2
3.15
EBITDA 비율에 대한 기업 가치
-8.99
-4.96
-0.63
—
—
—
—
Profitability ratios
Return on assets %
-0.5
-0.56
-1.03
-1.01
-1.75
-0.61
-1.99
Return on equity %
-0.56
-0.6
-1.12
-1.16
-2.25
-0.66
-2.7
Return on invested capital %
-65.28 K
-453.83 K
-1.85 M
-2.09 M
-1.11 M
-1.14 M
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-4 348.03
-10.48 K
-1 789.46
-2 012.97
-22.38 K
74.61 K
-19.07 K
EBITDA margin %
-4 247.76
-10.38 K
-1 689.46
—
—
—
—
Net margin %
-4 249.24
-10.49 K
-1 742.8
-1 917.65
-21.33 K
72.45 K
-17.99 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
9.37
14.83
12.26
8
4.45
14.62
26.87
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.01
0.05
0.04
0.01
-0
-0
Solvency ratios
Debt to assets ratio
0
—
—
—
—
—
—
Debt to equity ratio
0
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-3.5
-1.72
-1.72
-1.16
-1.36
EBIT per share
—
—
-5.14
-3.27
-2.77
-1.5
-1.73
EBITDA per share
—
—
-5.14
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
5.01
3.2
1.49
2.36
4.29
Net current asset value per share
—
—
5.16
3.24
1.52
2.38
4.37
Tangible book value per share
—
—
4.74
2.84
1.18
2.19
3.69
Working capital per share
—
—
4.74
2.83
1.18
2.22
3.73
Book value per share
—
—
4.74
2.84
1.18
2.19
3.69
뉴스
Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?
Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)
Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript
미주호, 렐마다 암 치료 데이터 긍정적...투자의견 ’매수’ 유지
Mizuho reiterates Relmada stock rating on positive cancer trial data
RLMD Stock Surges 42% in a Week: Here's What You Should Know
Avago, Lumentum among market cap stock movers on Monday
Tesla and Facebook among market cap stock movers on Monday
미주호, 방광암 임상 데이터에 렐마다 주식 등급 재확인
Mizuho reiterates Relmada stock rating on bladder cancer trial data
Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip
Hims & Hers 주가 장전 급등, 화이자와 Agilent Technologies 하락